AMNEAL PHARMACEUTICALS — Federal Lobbying Profile

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 5 of its records are shown together here.

Filings

Filed by

Reported in-house

$3,890,000

Reported by firms

$1,995,000

These two are not added together. An organisation lobbying for itself reports its own spending, and the firms it retains report what they were paid; the rules ask the first to include the second, but filings do not always do so and a filing gives no way to tell. Each is shown as reported.

Reported lobbying by year

The larger of in-house and firm-reported each year, $ millions 2013 to 2026

Filings

72 filings, newest first.

Filing	Filed by	Amount
3rd Quarter - Report 3rd Quarter 2026	AMNEAL PHARMACEUTICALS	$210,000 reported
3rd Quarter - Report 3rd Quarter 2026	TARPLIN, DOWNS & YOUNG, LLC	$60,000 reported
3rd Quarter - Report 3rd Quarter 2026	OGR	$20,000 reported
2nd Quarter - Report 2nd Quarter 2026	AMNEAL PHARMACEUTICALS	$190,000 reported
2nd Quarter - Report 2nd Quarter 2026	OGR	$20,000 reported
2nd Quarter - Report 2nd Quarter 2026	TARPLIN, DOWNS & YOUNG, LLC	$60,000 reported
1st Quarter - Report 1st Quarter 2026	AMNEAL PHARMACEUTICALS	$190,000 reported
1st Quarter - Report 1st Quarter 2026	TARPLIN, DOWNS & YOUNG, LLC	$60,000 reported
1st Quarter - Report 1st Quarter 2026	OGR	$20,000 reported
4th Quarter - Report 4th Quarter 2025	TARPLIN, DOWNS & YOUNG, LLC	$60,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

Firm	Reports	Amount
AMNEAL PHARMACEUTICALS In-house	11	$3,890,000
BROWN RUDNICK LLP	22	$745,000
TARPLIN, DOWNS & YOUNG, LLC	11	$660,000
FIERCE GOVERNMENT RELATIONS	8	$450,000
OGR	7	$140,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

Issue	Code	Mentions
Health Issues	HCR	42
Pharmacy	PHA	21
Budget/Appropriations	BUD	11
Manufacturing	MAN	8
Medicare/Medicaid	MMM	3
Copyright/Patent/Trademark	CPT	2
Trade (domestic/foreign)	TRD	1

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

Bill	Congress	Times named
H.R. 2841	114th	7
H.R. 2725	113th	7
S. 1176	117th	4
H.R. 2212	115th	4
S. 974	115th	4
H.R. 3204	113th	4
S. 3311	118th	3
H.R. 5378	118th	3
S. 2082	118th	3
S. 3056	114th	3
H.R. 1919	113th	3
S. 2780	118th	2
H.R. 1503	118th	2
H.R. 2880	118th	2
S. 2305	118th	2
S. 2916	118th	2
S. 2226	118th	2
H.R. 5429	118th	2
H.R. 2670	118th	2
H.R. 6109	118th	2
H.R. 2051	115th	2
S. 524	114th	2
H.R. 4976	114th	2
S. 1137	114th	2
H.R. 4981	114th	2

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.